2023 annual financial data
Aurinia Pharmaceuticals 2023 Operating margin
Aurinia Pharmaceuticals 2023 operating margin with verified reported values.
Direct answer
Operating margin was -52.24%.
Operating income was -91,691,000 USD and net income was -78,020,000 USD.
Operating cash flow was -33,461,000 USD.
Get free Aurinia Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 175,513,000 USD
- Operating income
- -91,691,000 USD
- Net income
- -78,020,000 USD
- Operating cash flow
- -33,461,000 USD